x
Visit our new Mobile Website next time you access NetDania with your mobile device

PLUS THERAPEUTICS INC. - COMMON STOCK

1.6900
26-19:59:59 GMT
+0.0250
+1.5015%
Today's Range
1.6000 - 1.7000
ISIN:N/A

Figures - PLUS THERAPEUTICS INC. - COMMON STOCK

Open
1.6000
Close
1.6650
Year Change
-3.4341
Year % Change
-3.4341%
52 Week High
5.0900
52 Week Low
0.9694
Volume
16331
Inc. Vol
100

News - PLUS THERAPEUTICS INC. - COMMON STOCK

29-12:02 GMT
Witty Retro Crime Drama ‘Chief Detective 1958’ Has U.S. Debut In May
Source: Forbes World, Symbol: PLUS THERAPEUTICS INC. - COMMON STOCK
29-12:02 GMT
The Flaw in Artificial Intelligence’s Limitless Potential
Source: Forbes World, Symbol: PLUS THERAPEUTICS INC. - COMMON STOCK
29-12:02 GMT
Taylor Swift Ties Jay-Z For The Most No. 1 Albums Of All Time By A Solo Musician
Source: Forbes World, Symbol: PLUS THERAPEUTICS INC. - COMMON STOCK
29-12:02 GMT
Sayonara! Will The Noncompete Ban Fuel Quitting?
Source: Forbes World, Symbol: PLUS THERAPEUTICS INC. - COMMON STOCK
29-12:02 GMT
Sales Solves All: ChatGPT Prompts To Make Business Problems Vanish
Source: Forbes World, Symbol: PLUS THERAPEUTICS INC. - COMMON STOCK
29-12:02 GMT
Oh, Canada: U.S. Patients Don't Want Your Health Policies
Source: Forbes World, Symbol: PLUS THERAPEUTICS INC. - COMMON STOCK
29-12:02 GMT
Mother’s Day Gift Guide 2024: The Best Eco-Friendly Home Gifts
Source: Forbes World, Symbol: PLUS THERAPEUTICS INC. - COMMON STOCK
29-12:02 GMT
Mastering Emotional Intelligence In Four Easy Steps: The STAR Method
Source: Forbes World, Symbol: PLUS THERAPEUTICS INC. - COMMON STOCK
29-12:02 GMT
Exploring The Advantages Of Nearshoring In Mexico's Northeastern Region
Source: Forbes World, Symbol: PLUS THERAPEUTICS INC. - COMMON STOCK
29-12:02 GMT
Meta Platforms Stock Dropped 10.6% In A Day, What’s Next?
Source: Forbes World, Symbol: PLUS THERAPEUTICS INC. - COMMON STOCK
29-12:02 GMT
Are Your Generative AI Use Cases Serving Up American Cheese Or Rich Stilton?
Source: Forbes World, Symbol: PLUS THERAPEUTICS INC. - COMMON STOCK
29-12:02 GMT
‘Alien’ 45th Anniversary: Reviewing The Sci-Fi Horror Classic New 4K Release
Source: Forbes World, Symbol: PLUS THERAPEUTICS INC. - COMMON STOCK
29-11:58 GMT
What's in Store for Intercontinental (ICE) in Q1 Earnings?
Source: NASDAQ Stocks, Symbol: PLUS THERAPEUTICS INC. - COMMON STOCK
29-11:48 GMT
Enjoying Montepulciano Two Ways In Abruzzo
Source: Forbes World, Symbol: PLUS THERAPEUTICS INC. - COMMON STOCK
29-11:47 GMT
BlackRock CEO Is Wrong: Why Endless Growth Of Capital Markets Is Not The Answer
Source: Forbes World, Symbol: PLUS THERAPEUTICS INC. - COMMON STOCK
29-11:47 GMT
How Healthcare Leaders Can Proactively Identify And Address Employee Burnout
Source: Forbes World, Symbol: PLUS THERAPEUTICS INC. - COMMON STOCK
29-11:47 GMT
Futuristic AI Needs Futuristic Data Centers, And It’s Just Starting
Source: Forbes World, Symbol: PLUS THERAPEUTICS INC. - COMMON STOCK
29-11:47 GMT
Components Of A Culture Of Continuous Improvement
Source: Forbes World, Symbol: PLUS THERAPEUTICS INC. - COMMON STOCK
29-11:47 GMT
Christina Westley Shows How To Create Your Own Table With ‘Social Setting’
Source: Forbes World, Symbol: PLUS THERAPEUTICS INC. - COMMON STOCK
29-11:47 GMT
Offering Solutions Without Diagnosis Is The Opposite Of Expert Advice
Source: Forbes World, Symbol: PLUS THERAPEUTICS INC. - COMMON STOCK
29-11:47 GMT
JinkoSolar Q1 Profit Declines - Update
Source: NASDAQ US Markets, Symbol: PLUS THERAPEUTICS INC. - COMMON STOCK
29-11:47 GMT
Cullinan Therapeutics Appoints Fenton As CFO
Source: NASDAQ US Markets, Symbol: PLUS THERAPEUTICS INC. - COMMON STOCK
29-11:47 GMT
Donaldson To Buy 49% Stake In Medica
Source: NASDAQ US Markets, Symbol: PLUS THERAPEUTICS INC. - COMMON STOCK
29-11:47 GMT
This Warren Buffett Dividend King Stock Just Invested $1.1 Billion Into Artificial Intelligence (AI)
Source: NASDAQ US Markets, Symbol: PLUS THERAPEUTICS INC. - COMMON STOCK
29-11:47 GMT
JinkoSolar Holding Co. Q1 24 Earnings Conference Call At 8:30 AM ET
Source: NASDAQ US Markets, Symbol: PLUS THERAPEUTICS INC. - COMMON STOCK
29-11:47 GMT
Can This Top Warren Buffett Stock Become a Trillion-Dollar Company by 2050?
Source: NASDAQ US Markets, Symbol: PLUS THERAPEUTICS INC. - COMMON STOCK
29-11:47 GMT
ONO To Acquire Deciphera; Total Equity Value Of Deal At Approx. $2.4 Bln
Source: NASDAQ US Markets, Symbol: PLUS THERAPEUTICS INC. - COMMON STOCK
29-11:47 GMT
Why Investors Had a Meltdown Over Virgin Galactic's Reverse Split News
Source: NASDAQ US Markets, Symbol: PLUS THERAPEUTICS INC. - COMMON STOCK
29-11:47 GMT
2 Stocks I'm Not Ready to Sell -- But I'm Seeing Some Big Red Flags
Source: NASDAQ US Markets, Symbol: PLUS THERAPEUTICS INC. - COMMON STOCK
29-11:47 GMT
1 Top Cryptocurrency to Buy Before It Hits a $1 Trillion Valuation, According to Cathie Wood
Source: NASDAQ US Markets, Symbol: PLUS THERAPEUTICS INC. - COMMON STOCK
Five Star Chart – Build your favorite menu, 100+ studies, for mobile and desktop
Find a Top Broker
Global
Forex
38329.04
58.68
0.15%
5117.39
14.66
0.29%
17805.89
83.89
0.47%
62301.00
-915
-1.45%
18219.63
-25.35
-0.14%
38471.11
73
0.19%
3113.04
24.4
0.79%
8189.62
19.98
0.24%
17760.57
152
0.86%
7647.17
47.38
0.62%
22643.40
223.45
1.00%
2335.68
-1.58
-0.07%
88.95
-0.344
-0.39%
1.07199
0.00296
0.28%
156.265
-2.028
-1.28%
1.25405
0.00694
0.56%
0.65680
0.00359
0.55%
1.36524
-0.00168
-0.12%
167.49000
-1.773
-1.05%
0.85479
-0.00098
-0.11%
195.96300
-1.404
-0.71%
0.91179
-0.00175
-0.19%
0.97745
0.00038
0.04%
0.59775
0.00394
0.66%
105.70900
-0.332
-0.31%
Top Gainers
Name
Last
+/-
%
0.03
0.02
210.00%
0.03
0.01
98.67%
0.13
0.06
85.71%
0.03
0.01
80.72%
1.30
0.58
79.36%
0.15
0.06
69.94%
0.10
0.04
66.11%
0.03
0.01
54.39%
7.35
2.24
43.84%
0.26
0.08
43.73%
Top Losers
Name
Last
+/-
%
5.04
-11.80
-70.06%
0.05
-0.08
-62.96%
0.01
-0.01
-55.14%
0.04
-0.05
-52.38%
1.24
-1.29
-50.99%
0.04
-0.04
-50.00%
0.03
-0.03
-46.25%
0.17
-0.12
-41.94%
0.08
-0.06
-39.29%
0.02
-0.01
-34.60%
NetDania does not guarantee the accuracy of data contained on this website, nor do we guarantee that data is real-time. Data on this website may be provided from OTC market sources and market makers, and not necessarily from exchanges. The provided price data is indicative and may not be appropriate for trading or decision making purposes. NetDania does not assume any responsibility for any losses incurred from the use of the provided data.
NetDania does not endorse or promote any broker or financial service. NetDania is a pure technology provider offering its software with broker integration. Any user of NetDania software must be an existing client of one of our supported brokers. NetDania showcases NetDania technology for the purpose of demonstrating it towards brokers and other institutions looking to white label the technology on a software subscription contract. No financial services are offered, promoted or recommended. NetDania is compensated as a technology provider by its institutional clients including its integrated brokers. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation affecting it.

Persons or entities including approved brokers not belonging to the NetDania Group may advertise on the NetDania and its Group’s websites, through links, banners or otherwise. We have not taken any steps to verify the accuracy, quality or reliability of any products, information or services provided by third parties that have links on our website. We accordingly provide no warranties with regard to and disclaim responsibility for any such products, information or services and exclude all liability in this regard to the fullest extent permitted by relevant laws and regulations. If a user of the NetDania Group’s websites decides to act upon any such advertising, such user does so entirely at its own risk.

NetDania’s website may be accessed worldwide. The Information provided on its website is however only intended for use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. None of the offerings services referred to on this website are available to recipients residing in countries where the provision of such offerings would constitute a violation of mandatory applicable legislation or regulations. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation.

HIGH RISK INVESTMENT WARNING:
End-users of the NetDania software that make use of the trading integration features as direct clients of integrated brokers, should be aware of the level of risk carried by trading in financial markets. Trading foreign exchange and or other financial instruments on margin carries a high level of risk, and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. Before deciding to invest you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain a loss of some or more of your initial investment, and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading, and seek advice from your broker and or an independent financial advisor if you have any doubts. Anyone opening a live trading account needs to adhere to the laws of their local country as such laws may differ from country to country.
NetDania expressly disclaims any liability for any lost principal or profits which without limitation may arise directly or indirectly from the use of or reliance on information on our website or the use of our software with broker integration.
Copyright © 1998 -2024 NetDania Creations ApS, Holmens Kanal 7, 1060 Copenhagen K, Denmark, +4536988200, Contact NetDania by email, CVR-nr.27976670 Terms And Conditions and Privacy Policy